Literature DB >> 315995

Influence of the sex-linked defect in CBA/N mice on autoimmune responses to isologous erythrocytes. Ability to overcome the defect with age.

Y J Rosenberg.   

Abstract

Normal mice spontaneously develop plaque-forming cells (PFC) specific for antigens on modified self erythrocytes (bromelain-treated mouse erythrocytes [BrMRBC] antigens). Our study demonstrates that the sex-linked defect that results in the inability of CBA/N mice to respond to several T-independent antigens (TI-2 antigens) also regulates the autoantibody response to BrMRBC antigens. Thus, in CBA/N homozygous mice and male F1 offspring of CBA/N-mothered crosses, e.g., (CBA/N X NZB)F1 males, such PFC are absent. To examine whether specific autoreactive B cells are present in defective mice, the latter were stimulated either nonspecifically with the mitogen LPS or by infection with lethal malaria (17XL Plasmodium yoelii) known to induce anti-BrMRBC PFC specifically. The results indicate that modest antibody responses to self antigens could be induced in young (5- to 7-wk old) defective mice and that these responses increased as a function of age. The data is consistent with the view that the defect in CBA/N mice does not result from an absence of functional anti-BrMRBC B cells but rather from low frequencies of the specific precursors, which can be triggered and expanded with age probably by environmental stimulations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315995      PMCID: PMC2185717          DOI: 10.1084/jem.150.6.1561

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Autoimmune and polyclonal B cell responses during murine malaria.

Authors:  Y J Rosenberg
Journal:  Nature       Date:  1978-07-13       Impact factor: 49.962

Review 2.  Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes.

Authors:  D E Mosier; I M Zitron; J J Mond; A Ahmed; I Scher; W E Paul
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

3.  The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect.

Authors:  D E Mosier; J J Mond; E A Goldings
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

4.  T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus.

Authors:  J J Mond; I Scher; D E Mosier; M Baese; W E Paul
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

5.  Induction of B cell priming by neonatal injection of mice with thymic-independent (type 2) antigens.

Authors:  D E Mosier
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

6.  Gene action in the X-chromosome of the mouse (Mus musculus L.).

Authors:  M F LYON
Journal:  Nature       Date:  1961-04-22       Impact factor: 49.962

7.  Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice.

Authors:  P W Kincade
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

8.  Generation of anti-type III pneumococcal polysaccharide hybridomas from mice with an X-linked B-lymphocyte defect.

Authors:  K R Schroer; K J Kim; B Prescott; P J Baker
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

9.  Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect.

Authors:  R M Perlmutter; M Nahm; K E Stein; J Slack; I Zitron; W E Paul; J M Davie
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

10.  CBA/N X-linked B-cell defect prevents NZB B-cell hyperactivity in F1 mice.

Authors:  J D Taurog; H M Moutsopoulos; Y J Rosenberg; T M Chused; A D Steinberg
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

View more
  1 in total

1.  Opposing effects of xid and nu mutations on proliferative and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A and PWM.

Authors:  R Dziarski
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.